Validation of plasma biomarker immunoassay-based models for predicting brain amyloid positivity in cognitively impaired individuals.

Published

Research record: Validation of plasma biomarker immunoassay-based models for predicting brain amyloid positivity in cognitively impaired individuals.

Published in Alzheimers Dement; first publication date 2026-11-01. PMID 42982748.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-11-01

Updated

2026-11-16

Disclaimer

professional use

Explorar más